Hello, everyone, and how are you today? Another steamy day is rapidly unfolding and, to prepare, we are brewing - what else? - a hot cup of stimulation. As always, you are invited to join us. We would also like to remind you that we are hosting a
webinar next Wed at 1 pm ET on health care payers and players, so please tune in. Meanwhile, there is much to do today, so time to get started. Here are some tidbits you may find useful. Have a successful day and keep in touch if you hear anything interesting...FDA Panel Backs Onyx Drug For Multiple Myeloma (Bloomberg News)
CDC Recommends Expanded Use For Pfizer Prevnar 13 Vaccine (Reuters)
South Carolina Governor Vetoes Bill For Access To HPV Vaccines (Associated Press)
Merck In Talks To Buy Indian API Maker (Dow Jones)
Roche Cuts MabThera Price In South Africa (Business Day)
FDA Panel Rejects Sanofi Clotting Drug For Chemo Patients (Reuters)
Spain Raises Prices For Chronic Meds Sharply (Pharma Times)
Daiichi To Market Ranbaxy Drugs In Venezuela (Economic Times)
EDITOR'S NOTE: Please check this post for updates during the day
2 Comments